The U.S. Drug Enforcement Administration has offered federal lawmakers a rare glimpse into the ongoing marijuana rescheduling process.
However, an April 16 letter from the agency noting it is “carefully following” protocol while weighing a potentially revolutionary change to federal drug laws did not satisfy 21 leading Democratic lawmakers.
ADVERTISEMENT
The legislators told the DEA in an April 24 follow-up that “it is time to make good on the President’s commitments” to enact marijuana reform.
That was a reference to President Joe Biden’s October 2022 order to cabinet-level agencies to “expeditiously review” marijuana’s Schedule 1 status under the Controlled Substances Act (CSA).
Long wait
Advocates and players in the regulated U.S. marijuana industry are waiting on the DEA to rule on a subsequent August
Read full article on Marijuana Business Daily
